Managing Logistics in CGT White Paper

Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies

Proper logistics management for cell and gene therapies, particularly during clinical trials, is an intense process requiring meticulous planning, execution and oversight. These therapies are exceptionally time- and temperature-sensitive, requiring efficiency and precise maintenance of transport and storage conditions. This white paper explores:

• The precise and regulated steps — tailored to the type of therapy being produced — that comprise the journey of cell and gene therapy products, from study design to patient receipt.
• The importance of efficient supply chain operation in preventing any disruption that could compromise the integrity of samples or the timely treatment of patients.
• The stringent storage and stability protocols required to preserve the biological integrity of cell and gene therapies and ensure their viability and efficacy through precise temperature regulation, robust packaging, and continuous monitoring to avert degradation during storage and transit.

Our expansive infrastructure, including a dedicated support group, regulatory and trade compliance expertise, a global depot network, and a wealth of cold-chain management knowledge, fortifies our capacity to handle the escalating demands and scalability of CGT trials.